Athos Therapeutics

Athos Therapeutics is a clinical-stage biopharmaceutical company in Torrance, California developing precision small-molecule therapeutics for autoimmune and chronic inflammatory diseases, led by co-founder and CEO Dr. Dimitrios Iliopoulos. Its AI/ML discovery platform integrates multi-omic patient data — genomics, transcriptomics, proteomics, epigenomics, metabolomics and microbiomics — collected with global hospital systems to identify novel drug and gene targets, and produced ATH-063, an AI-generated G9A methyltransferase inhibitor advancing in inflammatory bowel disease. The computational side of the business is commercialized through Chiron AI Labs (formerly AthosOmics.AI), a deliberately no-code omics analysis SaaS suite (Athos-Multi, Athos-T, Athos-P, Athos-G, Athos-PM) that is pre-launch and gated behind a demo waitlist. Athos publishes no public API, developer portal, SDK or machine-readable specification.

Athos Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Drug Discovery.

Athos Therapeutics’ developer surface includes engineering blog, support, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

6.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyPharmaceuticalsLife SciencesDrug DiscoveryArtificial IntelligenceMachine LearningGenomicsPrecision MedicineHealth

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 6.5/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/athos-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Company 6

The organization behind the API

Website

Blog

BlogRSS

Careers

LinkedIn

Twitter

Twitter

Other 3

Properties that don't map to a standard resource type

Team

Team

Product

Product

Company

Company

Source (apis.yml)

aid: athos-therapeutics
name: Athos Therapeutics
description: Athos Therapeutics is a clinical-stage biopharmaceutical company in Torrance, California developing precision
  small-molecule therapeutics for autoimmune and chronic inflammatory diseases, led by co-founder and CEO Dr. Dimitrios Iliopoulos.
  Its AI/ML discovery platform integrates multi-omic patient data — genomics, transcriptomics, proteomics, epigenomics, metabolomics
  and microbiomics — collected with global hospital systems to identify novel drug and gene targets, and produced ATH-063,
  an AI-generated G9A methyltransferase inhibitor advancing in inflammatory bowel disease. The computational side of the business
  is commercialized through Chiron AI Labs (formerly AthosOmics.AI), a deliberately no-code omics analysis SaaS suite (Athos-Multi,
  Athos-T, Athos-P, Athos-G, Athos-PM) that is pre-launch and gated behind a demo waitlist. Athos publishes no public API,
  developer portal, SDK or machine-readable specification.
image: https://athostx.com/wp-content/uploads/2020/04/athos-favicon.jpg
url: https://raw.githubusercontent.com/api-evangelist/athos-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Genomics
- Precision Medicine
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/athos-therapeutics-domain-security.yml
- type: Website
  url: https://athostx.com/
- type: Blog
  url: https://athostx.com/news-posts/
- type: BlogRSS
  url: https://athostx.com/feed/
- type: Support
  url: https://athostx.com/contact/
- type: Careers
  url: https://athostx.com/careers/
- type: Team
  url: https://athostx.com/ourteam/
- type: Product
  url: https://chironailabs.com/our-products
- type: Company
  url: https://chironailabs.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/athostx
- type: Twitter
  url: https://twitter.com/athostx
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Athos is a clinical-stage biotech whose only software product, the Chiron AI Labs omics suite (formerly AthosOmics.AI),
    is marketed explicitly as "no-code" and is pre-launch behind a demo-waitlist email form; the eight-page athostx.com sitemap
    contains no developer, docs or API page and every well-known/spec path on both hosts returns 404.
  evidence:
  - url: https://athostx.com/page-sitemap.xml
    status: 200
  - url: https://athostx.com/openapi.json
    status: 404
  - url: https://athostx.com/.well-known/agent-card.json
    status: 404
  - url: https://chironailabs.com/openapi.json
    status: 404
  - url: https://chironailabs.com/llms.txt
    status: 404
  - url: https://api.athostx.com/
    status: 0
  checked: '2026-08-06'